Linked Life Data

16504726

Source:http://linkedlifedata.com/resource/pubmed/id/16504726

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-2-28
pubmed:abstractText
Islet cell transplantation is a promising method to restore insulin independence to patients with type 1 diabetes mellitus. A main problem in clinical islet transplantation is the fact that only a small percentage of allogeneic islet-transplanted type 1 diabetic patients can completely omit insulin injections after transplantation. One reason for the impaired survival of islet grafts is aberration of the function of islets due to toxic agents, including oxygen radicals and nitric oxide, which arise during warm or cold ischemic time. Therefore, in clinical islet transplantation, islets have been preserved with a mixture of antioxidants to reduce free radical-mediated damage of transplanted beta cells. Our aim was to examine hepatic tissue after metabolic normalization following intraportal islet transplantation after application of sulforaphane.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
282-3
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:articleTitle
Application of sulforaphane: histopathological study of intraportal transplanted pancreatic islets into livers of diabetic rats.
pubmed:affiliation
Department of General and Transplant Surgery, Warsaw Medical University, ul. Nowogrodzka 59, 02-006 Warsaw, Poland. ewa-solowiej@wp.pl
pubmed:publicationType
Journal Article, Retracted Publication